Evaluating Optimal Timing of Endocrine Therapy and Radiation Therapy in Early-stage Breast Cancer (REaCT-RETT)
Condition: Early-stage Breast Cancer Intervention: Combination Product: Endocrine Therapy and Radiotherapy Sponsor: Ottawa Hospital Research Institute Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Breast Cancer | Cancer | Cancer & Oncology | Endocrine Therapy | Radiation Therapy | Research